Trulieve Cannabis (TCNNF) Current Deferred Revenue (2020 - 2026)

Trulieve Cannabis' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $10.0 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue rose 14.62% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $10.0 million (up 14.62% YoY), while the FY2025 annual figure was $9.6 million, up 19.49% from the prior year.
• Current Deferred Revenue was $10.0 million for Q1 2026 at Trulieve Cannabis, up from $9.6 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $10.0 million in Q1 2026 to a low of $1.3 million in Q4 2023.
• Historically, Current Deferred Revenue has averaged $6.5 million across 5 years, with a median of $6.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Current Deferred Revenue sank 85.89% in 2023, then soared 501.35% in 2024.
• A 5-year view of Current Deferred Revenue shows it stood at $9.5 million in 2022, then tumbled by 85.89% to $1.3 million in 2023, then jumped by 501.35% to $8.0 million in 2024, then increased by 19.49% to $9.6 million in 2025, then increased by 3.76% to $10.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $10.0 million (Q1 2026), $9.6 million (Q4 2025), and $8.9 million (Q3 2025), per Business Quant data.